| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Sep 17, 2021 | Agarwal Sunil EVP Head of Development CMO | Sell | Sana Biotechnology, Inc. | SANA | $26.07 | $2M | -3.73% |
| Oct 02, 2017 | Oct 04, 2017 | Agarwal Sunil Pres of R D | Sell | Juno Therapeutics, Inc. | JUNO | $44.76 | $326,088 | -7.93% |
| Jul 21, 2016 | Jul 21, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $52.68 | $34,189 | -6.38% |
| Jun 20, 2016 | Jun 21, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $54.16 | $35,204 | -5.79% |
| May 24, 2016 | May 26, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $66 | $42,900 | -8.38% |
| Apr 20, 2016 | Apr 21, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $70.53 | $45,774 | -7.04% |
| Mar 22, 2016 | Mar 24, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $61.45 | $39,943 | -6.34% |
| Feb 22, 2016 | Feb 23, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $63.48 | $41,770 | -5.82% |
| Jan 20, 2016 | Jan 21, 2016 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $72.83 | $42,606 | -4.58% |
| Dec 22, 2015 | Dec 24, 2015 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $114.81 | $57,175 | -3.63% |
| Nov 23, 2015 | Nov 24, 2015 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $95.88 | $47,748 | -3.49% |
| Oct 20, 2015 | Oct 21, 2015 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $85.51 | $55,496 | -4.20% |
| Sep 22, 2015 | Sep 24, 2015 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $109.51 | $54,536 | -3.04% |
| Aug 20, 2015 | Aug 21, 2015 | Agarwal Sunil Chief Medical Officer | Sell | Ultragenyx Pharmaceutical Inc. | RARE | $111.18 | $2M | -50.18% |